Allergic rhinitis is the most common chronic conditions in children [1••] . Approximately 20 to 30% of the population is atopic, and the prevalence is increasing [2] . Almost half of new patients evaluated by an otolaryngologist have complaints related to upper respiratory allergies [3] .
The prevalence of any form of pediatric rhinitis is difficult to ascertain. Allergic rhinitis and infectious rhinitis often act in concert and may coexist. Allergic rhinitis initially presents in childhood and may persist for years. Prevalence increases with age. Approximately 1% of infants, 5% of children aged 5 to 9 years, and 15% of adolescents have allergic rhinitis, which declines in later adulthood [4] .
Allergic reactions result in nasal congestion, increased mucus production, and obstruction of airflow and drainage. Mucosal edema and obstruction of sinus ostia predispose the affected child to conditions such as sinusitis and asthma. Abnormal findings on sinus radiographs may be found in as many as 70% of children with allergic rhinitis [5, 6] . These abnormalities may indicate sinusitis, as the prevalence of allergy in patients with sinusitis is much higher than in healthy patients [7] . As many as 80% of children with sinusitis have inhalant allergies and 97% have a history of food allergies [8] .
Allergic rhinitis impacts the quality of life of children and their families [9, 10] . Children miss days of school, and parents lose days from work. In 1990 costs for treating allergic rhinitis were estimated at $1.16 billion and $639 million was lost because of missed work days [11] . Sleep disturbances and daytime fatigue related to allergic rhinitis lead to decreased attention, impaired learning, and poor school performance. Vuurman et al. [12] reported that allergic children have impaired learning ability and processing of cognitive input when compared with their nonallergic peers. Allergic rhinitis may adversely affect social development [13] . Associated conditions such as otitis media with effusion (OME) may impact hearing and speech development.
parents have allergies and approaches 72% when they have the same manifestations [2]. These genetic components control the immune system response to allergens.
Immunologic mechanisms
Activation of the atopic response requires two distinct phases of immune system activity. Initial exposure to the antigen leads to sensitization of the immune system. Subsequent exposures result in the atopic reaction.
Aeroallergens are inhaled and deposited on the mucosal surfaces of the upper respiratory tract. They are processed by antigen-presenting cells (eg, macrophages) that activate B cells to produce IgE, the subclass of immunoglobulins critical for the atopic response. Antigen-specific IgE molecules are bound by mediator cells (eg, eosinophils, basophils, and mast cells) in preparation for the reaction phase. Future antigen exposure initiates to the early phase of the atopic response a Gell and Coombs type I hypersensitivity reaction [19] . Within minutes cellular signaling events direct the release of mediators for eosinophils, mast cells, and basophils including histamines, neutral proteases, acid hydrolases, cathepsin G, and carboxypeptidases. Vasodilation in the mucosa is influenced by histamines, and kinins cause edema and congestion. Although the histamines also affect these symptoms, prostaglandins promote nasal itching, and leukotrienes cause sneezing and stimulate watery secretions.
The late-phase response is influenced by factors released primarily by mast cells and basophils, including lipid mediators (leukotrienes and prostaglandins) and cytokines (interleukins and tumor necrosis factor-␣ [20] . This response is a cellular, inflammatory response rather than a humoral one. The increased vascular permeability, continued tissue edema, and cellular recruitment in the 4 to 24 hours following antigen exposure lead to the obstructive symptoms.
Continued inflammation causes loss of surface epithelium and basement membrane thickening. Hyperplasia of mucus-producing cells increases secretions and alters mucus composition. Ciliary dyskinesia further impairs mucus transport and nasal airflow. Nasal hyperreactivity is also related to increased levels of nerve growth factor in the nasal mucosa and increased secretions in patients with perennial allergic rhinitis, which may lead to changes in sensory nerve sensitivity in the mucosa [21•].
In patients who remain in a continuous late-phase response, inflammatory cells continue to be recruited to the mucosa and release more of their mediators, increasing hyperactivity to histamines and nonallergic stimuli (eg, tobacco smoke or smog) [22••] . The accumulation of inflammatory cells and mucosal injury causes priming of the nasal mucosa as smaller amounts of allergen are required to elicit further response.
Allergens
Many environmental stimuli induce and exacerbate allergic rhinitis [23] . Most allergens can be categorized by their temporal appearance. Many airborne allergens are seasonal [24] . Tree pollens are present between March and May whereas grass pollens appear during May to July. Weeds follow in August and September, and outdoor molds persist from July to September. These patterns are only guidelines and vary by location.
Children with allergic rhinitis due to sensitivities to perennial allergens are less likely to have their condition resolve than patients with other types of allergic rhinitis [25] . The most common perennial allergen affecting children is produced by dust mites. Children also develop sensitivity to roaches, indoor pets (especially cats), and indoor molds.
Food allergies must be considered in children with abnormal response to intake and no apparent sensitivity to airborne allergens. Food allergies may have cutaneous, gastrointestinal, and nasal manifestations [26] . In infancy, food allergies are more common than inhalant allergies. Non-breast fed infants are more likely to develop food sensitivities at an early age, especially to milk.
Food sensitivities present in two forms: fixed and cyclic. Fixed allergies are the immediate type I hypersensitivity reactions identical to the early-phase response to aeroallergens. Cyclic allergies are immune complex-mediated type III and IV responses and may be more difficult to diagnose because of the delayed onset of symptoms. Diagnosis of cyclic allergies requires a high index of suspicion and careful symptom and diet observation.
Testing for food allergies involves complete food elimination for 4 to 5 days and challenge testing in a controlled setting on the 5th day. The allergic response may be provoked due to antibody excess.
Comorbid associations of allergic rhinitis Sinusitis
The prevalence of allergic rhinitis in patients with sinusitis is well documented [27, 28] . Mucosal swelling, eosinophil infiltration, and ciliostasis contribute to obstruction of sinus ostia and accumulation of secretions, creating an ideal environment for infection. Yaniv et al.
[29] treated children with chronic sinusitis with antihistamines or antibiotics. Although both forms of medication were beneficial, antihistamines were more effective in children older than 6 years of age, suggesting that treatment of pediatric sinusitis should address the bacterial infection and allergies.
Otitis media
Although the causal relation remains uncertain, 35 to 50% of children with OME have allergic rhinitis, and 21% with allergic rhinitis have OME [30, 31] . Eustachian tube function may be altered by allergies [32] . Evaluation for allergic rhinitis and appropriate management may benefit children with OME. Allergic rhinitis appears to precede the development of asthma. Atopy is "the strongest identifiable predisposing factor for the development of asthma" [34] . Early treatment for allergic rhinitis may have a positive influence on lower airway dynamics. Although treatment for allergic rhinitis may not prevent the development or improve asthma, appropriate management likely prevents its exacerbation [13,33,35•].
Nasal polyps
There is no direct relation between allergic rhinitis and nasal polyps [36] . Patients with nasal polyps may present with symptoms similar to allergic rhinitis. However, adequate management of allergic rhinitis may decrease the recurrence of polyps [37] .
Management Clinical approach
Identification of the child with allergic rhinitis can be difficult and requires a high index of suspicion. The presentation can change with age, but allergic rhinitis should be suspected in children with a family history of allergies, multiple drug allergies, and related illnesses and in infants with colic or feeding problems [38] . Children may become accustomed to their symptoms and not complain. Because parents often provide a history, they need to be aware of the signs and symptoms, to document specific episodes of sensitivity, and to help estimate the exposure to potential allergens.
The likelihood of allergy causing upper respiratory tract symptoms increases with age. Infants less than 6 months of age are rarely sensitized to aeroallergens. Crawling exposes infants to allergens, and by 2 years, approximately 20% of children with chronic respiratory symptoms have positive skin test results, especially to indoor aeroallergens [17] . The prevalence of positive skin test results increases with age, especially in children with chronic respiratory symptoms, and peaks in the second decade.
Itching and sneezing are the most common symptoms of allergic rhinitis [23] . Children may complain of rhinorrhea, postnasal drip, palatal and ocular pruritis, excessive lacrimation, and nasal obstruction. They may present as mouth breathers. Infraorbital discoloration from periorbital edema and venous stasis results in "allergic shiners," and Dennie-Morgan lines, creases in the lower eyelid, may develop. A transverse nasal crease may appear from the "allergic salute," a constant upward rubbing of the nose. The nasal mucosa may appear edematous and pale blue.
The history and physical examination will often be sufficient to diagnosis allergic rhinitis. Increased numbers of eosinophils on nasal cytology will help confirm the diagnosis and exclude other forms of rhinitis. A successful empiric trial of antiallergy medications may suggest allergic rhinitis.
Treatment
Treatment is directed toward reducing inflammation and alleviating symptoms and may include a combination of environmental precautions, pharmacotherapy, immunotherapy, and surgery.
Environmental precautions
The elimination or reduction of the offending allergens is essential. This may include removal of indoor pets and measures to control dust mites, roaches, and indoor molds. High-efficiency central air filters and reduction of humidity to less than 50% can minimize mold and dust mite growth. Smoke should be eliminated, and outdoor activities should be avoided or restricted during relevant seasons. Food sensitivities are addressed through elimination and possibly challenge refeeding.
Pharmacotherapy
Patients typically require multiple medications as no single-agent relieves all symptoms of allergic rhinitis. The most profound change regarding medications is the increasing acceptance of intranasal steroids rather than antihistamines as first-line therapy.
Intranasal steroids
The local anti-inflammatory action of intranasal steroids relieves sneezing, pruritis, rhinorrhea, and mucosal edema [39] . Their beneficial effects result from the downregulation of cytokines produced by T H 2 cells with a subsequent decrease in eosinophils and IgE [40] . To be effective steroids must be used regularly, and there must be an adequate passage for the medication to reach the mucosa. Many preparations are available, but there is no difference in efficacy. The more potent preparations (fluticasone and mometasone) are preferred because of improved compliance with once daily dosing. These steroids demonstrate minimal systemic absorption.
Antihistamines
Antihistamines reduce sneezing, itching, and rhinorrhea but not congestion and obstruction [41] . The problem of sedation commonly associated with first-generation antihistamines has largely been eliminated by secondgeneration antihistamines, including loratadine and fexofenadine, whose most common side effect is mucosal drying.
Azelastine, an antihistamine with anti-inflammatory properties, is delivered as an aqueous nasal spray. Golden et al. [42] noted a reduction of rhinorrhea and improved sleep quality using azelastine but found no difference in the severity of congestion or daytime somnolence. Clinical trials suggest that azelastine is as effective as intranasal steroids in treatment of allergic rhinitis [19] .
Topical mast cell stabilizers
Topical cromolyn sodium diminishes immediate and late-phase mast cell-mediated reactions. Although it has a faster onset than steroids, cromolyn sodium is not as effective and is short acting, requiring up to four doses daily. No significant adverse reactions have been reported. It is also useful in anticipation of unavoidable allergen exposure.
Adjunctive therapies
Decongestants such as pseudoephedrine and oxymetazoline affect ␣-adrenergic receptors in the nasal mucosa. The resulting vasoconstriction decreases edema, improving nasal patency. Prior to initiating intranasal steroids, a short course may be used to gain access to the mucosa. Decongestants may cause agitation, sleeplessness, and hypertension. Rhinitis medicamentosa, a rebound congestion, is a potential problem.
Other agents may be used in conjunction with steroids and antihistamines. The anticholinergic effects of ipratropium bromide may alleviate rhinorrhea until the effects of the steroids occur. Although they are currently indicated only for the treatment of asthma, agents that block the actions of leukotrienes, such as zafirlukast and montelukast, may also be beneficial in managing allergic rhinitis [43, 44] .
Immunotherapy
If environmental precautions and pharmacotherapy fail to control symptoms, are impractical, or have significant side effects, immunotherapy should be considered. Children with sensitivity to one agent may gain more benefit than those with multiple allergies [15] . Immunotherapy may also be effective in children with symptoms for two or more seasons of the year or children with perennial allergies [45] . Immunotherapy may prevent the onset of additional sensitizations and the development of asthma [46, 47] .
Allergy testing is the cornerstone of immunotherapy, as a positive test result is necessary to target the appropriate allergen. Allergy testing may further demonstrate the need to institute and continue environmental precautions. The accepted mode of testing is skin endpoint titration (intradermal dilution testing). Scratch, prick, and single intradermal tests have many false-negative and false-positive results as well as interoperator variability. Laboratory tests such as radioallergosorbent tests detect allergen-specific IgE antibodies in serum, and the results must be correlated with clinical findings. Positive radioallergosorbent test findings may only indicate prior sensitization to an antigen.
Although the mechanism of immunotherapy is not well understood, current theories posit that neutralizing IgG antibodies are formed to allergens that would otherwise be bound by IgE molecules. Immunotherapy is a safe and effective treatment, with approximately one fatality per 2 million doses [48, 49] . It must be administered by an experienced physician who can manage adverse allergic reactions such as anaphylaxis. Eighty to eighty-five percent of patients gain significant symptomatic relief but may require long-term therapy. After 3 to 5 years of weekly injections, a reduction in the treatment frequency may be considered, and 60% of patients continue to benefit [50] .
Future delivery of immunotherapy may be targeted locally. Freeze-dried, powdered allergens have been delivered directly to the nasal mucosa. Trials with dust mite allergens and seasonal pollens have been well tolerated and have demonstrated efficacy [51] .
Surgery
If obstruction and congestion persist despite environmental precautions, pharmacotherapy, and immunotherapy, surgery remains an option. Inferior turbinate reduction to relieve nasal obstruction caused by allergic rhinitis is well established. Procedures include resection, cautery, laser surgery, radiofrequency, cryosurgery, and coagulation. Carbon dioxide laser surgery and argon plasma coagulation have also reduced the incidence of rhinorrhea and sneezing associated with allergic rhinitis [52, 53] . A possible mechanism for the relief of symptoms is a decrease in the expression of local inflammatory cytokines [53] .
Conclusions
Pediatric allergic rhinitis is a common chronic condition. Frequently, allergic rhinitis may precipitate or exacerbate other diseases such as sinusitis, OME, and asthma. Patients must be carefully assessed for allergic rhinitis and the antigen exposures that elicit the atopic response. A broad range of therapeutic modalities may improve quality of life, improve learning, and prevent the development of comorbid conditions.
